Cell growth and metastasis in pancreatic cancer: Is Vav the Rho'd to activation?

International Journal of Gastrointestinal Cancer

Volumn 31, Issue 1-3, 2002, Pages 5-13

  Billadeau, Daniel D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Guanine nucleotide exchange factor (GEF); Receptor tyrosine kinases; Rho GTP binding proteins; Vav

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; PROTEIN TYROSINE KINASE; RHO FACTOR; SOMATOMEDIN RECEPTOR;

CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0036934433     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:31:1-3:5     Document Type: Review

References (80)

1. Sahai E, Marshall CJ. RHO-GTPases and Cancer. Nat Rev Cancer 2002;2:133-142.
2. Fukata M, Kaibuchi K. Rho-family GTPases in cadherin-mediated cell-cell adhesion. Nat Rev Mol Cell Biol 2001;2:887-897.
3. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001;81:153-208.
4. Anastasiadis PZ, Reynolds AB. Regulation of Rho GTPases by p 120-catenin. Curr Opin Cell Biol 2001;13:604-610.
5. Ridley AJ. Rho family proteins: coordinating cell responses. Trends Cell Biol 2001;11:471-477.
6. Sachdev P, Jiang YX, Li W, et al. Differential requirement for Rho family GTPases in an oncogenic insulin-like growth factor-I receptor-induced cell transformation. J Biol Chem 2001;276:26,461-471.
7. Liu BP, Burridge K. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins. Mol Cell Biol 2000;20:7160-7169.
8. Zeng L, Sachdev P, Yan L, et al. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol 2000;20:9212-9224.
9. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27-36.
10. Bourguignon LY, Zhu H, Zhou B, et al. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem 2001;276:48,679-48,692.
11. Edlund S, Landstrom M, Heldin CH, et al. Transforming Growth Factor-beta-induced Mobilization of Actin Cytoskeleton Requires Signaling by Small GTPases Cdc42 and RhoA. Mol Biol Cell 2002;13:902-914.
12. Royal I, Lamarche-Vane N, Lamorte L, et al. Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol Cell 2000;11:1709-1725.
13. Sahai E, Ishizaki T, Narumiya S, et al. Transformation mediated by RhoA requires activity of ROCK kinases. Curr Biol 1999;9:136-145.
14. Schurmann A, Mooney AF, Sanders LC, et al. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol Cell Biol 2000;20:453-461.
15. Mira JP, Benard V, Groffen J, et al. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci USA 2000;97:185-189.
16. Vadlamudi RK, Adam L, Wang RA, et al. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 2000;275:36,238-36,244.
17. Miki H, Yamaguchi H, Suetsugu S, et al. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature 2000;408:732-735.
18. Tominaga T, Sahai E, Chardin P, et al: Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Mol Cell 2000;5:13-25.
19. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J 2000;348:241-255.
20. Katzav S, Martin-Zanca D, Barbacid M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. Embo J 1989;8:2283-2290.
21. Schuebel KE, Bustelo XR, Nielsen DA, et al. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. Oncogene 1996;13:363-371.
22. Movilla N, Bustelo XR. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol 1999;19:7870-7885.
23. Henske EP, Short MP, Jozwiak S, et al. Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC 1. Ann Hum Genet 1995;59:25-37.
24. Moores SL, Selfors LM, Fredericks J, et al. Vav family proteins couple to diverse cell surface receptors. Mol Cell Biol 2000;20:6364-6373.
25. Turner M, Billadeau DD. Vav proteins as signal integrators for multi-subunit immune recognition receptors. Nat Rev Immunol 2002;2:476-486.
26. Bustelo XR. Regulatory and signaling properties of the Vav family. Mol Cell Biol 2000;20:1461-1477.
27. Bustelo XR: Vav proteins, adaptors and cell signaling. Oncogene 2001;20:6372-6381.
28. Schuebel KE, Movilla N, Rosa JL, et al. Phosphorylationdependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. Embo J 1998;17:6608-6621.
29. Crespo P, Schuebel KE, Ostrom AA, et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997;385:169-172.
30. Movilla N, Dosil M, Zheng Y, et al. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42. Oncogene 2001;20:8057-8065.
31. Zheng Y: Db1 family guanine nucleotide exchange factors. Trends Biochem Sci 2001;26:724-732.
32. Bustelo XR. Regulation of Vav Proteins by Intramolecular Events. Front Biosci 2002;7:D24-D30.
33. Songyang Z, Shoelson SE, McGlade J, et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 1994;14:2777-2785.
34. Marignani PA, Carpenter CL. Vav2 is required for cell spreading. J Cell Biol 2001;154:177-186.
35. Chiariello M, Marinissen MJ, Gutkind JS. Regulation of c-myc expression by PDGF through Rho GTPases. Nat Cell Biol 2001;3:580-586.
36. Kato-Stankiewicz J, Ueda S, Kataoka T, et al. Epidermal growth factor stimulation of the ACK1/Db1 pathway in a Cdc42 and Grb2-dependent manner. Biochem Biophys Res Commun 2001;284:470-477.
37. Chikumi H, Fukuhara S, Gutkind JS. Regulation of G Protein-linked Guanine Nucleotide Exchange Factors for Rho, PDZ-RhoGEF, and LARG by Tyrosine Phosphorylation. Evidence of a Role for Focal Adhesion Kinase. J Biol Chem 2002;277:12,463-12,473.
38. Aghazadeh B, Lowry WE, Huang XY, et al. Structural basis for relief of autoinhibition of the Db1 homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 2000;102:625-633.
39. Lopez-Lago M, Lee H, Cruz C, et al: Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol Cell Biol 2000;20:1678-1691.
40. Billadeau DD, Mackie SM, Schoon RA, et al. Specific subdomains of Vav differentially affect T cell and NK cell activation. J Immunol 2000;164:3971-3981.
41. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001;20:7437-7446.
42. Suwa H, Ohshio G, Imamura T, et al. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 1998;77:147-152.
43. Fritz G, Just I, Kaina B: Rho GTPases are over-expressed in human tumors. Int J Cancer 1999;81:682-687.
44. Kamai T, Arai K, Tsujii T, et al: Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int 2001;87:227-231.
45. van Golen KL, Wu ZF, Qiao XT, et al. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 2000;60:5832-5838.
46. Abraham MT, Kuriakose MA, Sacks PG, et al. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 2001;111:1285-1289.
47. Preudhomme C, Roumier C, Hildebrand MP, et al. Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene 2000;19:2023-2032.
48. Schnelzer A, Prechtel D, Knaus U, et al. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000;19:3013-3020.
49. Jordan P, Brazao R, Boavida MG, et al. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 1999;18:6835-6839.
50. Lin R, Bagrodia S, Cerione R, et al. A novel Cdc42Hs mutant induces cellular transformation. Curr Biol 1997;7:794-797.
51. Adam L, Vadlamudi RK, McCrea P, et al. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1β-catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem 2001;276:28,443-28,450.
52. Kourlas PJ, Strout MP, Becknell B, et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000;97:2145-2150.
53. Murga C, Zohar M, Teramoto H, et al. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene 2002;21:207-216.
54. Coleman ML, Marshall CJ. A family outing: small GTPases cyclin' through G1. Nat Cell Biol 2001;3:E250-E251.
55. Joyce D, Bouzahzah B, Fu M, et al. Integration of Racdependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem 1999;274:25,245-25,249.
56. Mettouchi A, Klein S, Guo W, et al. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol Cell 2001;8:11.5-127.
57. Pruitt K, Der CJ. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett 2001;171:1-10.
58. Liberto M, Cobrinik D, Minden A. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 2002;21:1590-1599.
59. Welsh CF, Roovers K, Villanueva J, et al. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol 2001;3:950-957.
60. Joyce D, Albanese C, Steer J, et al. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev 2001;12:73-90.
61. Hinz M, Krappmann D, Eichten A, et al. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 1999;19:2690-2698.
62. Adnane J, Bizouarn FA, Qian Y, et al. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA. Mol Cell Biol 1998;18:6962-6970.
63. Olson MF, Paterson HF, Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 1998;394:295-299.
64. Zhuge Y, Xu J. Rac1 mediates type I collagen-dependent MMP-2 activation, role in cell invasion across collagen barrier. J Biol Chem 2001;276:16,248-16,256.
65. Matsumoto Y, Tanaka K, Harimaya K, et al. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells. Jpn J Cancer Res 2001;92:429-438.
66. Engers R, Springer E, Michiels F, et al. Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem 2001;276:41,889-41,897.
67. van Golen KL,Wu ZF, Qiao XT, et al. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2000;2:418-425.
68. Braga VM, Machesky LM, Hall A, et al. The small GTPases Rho and Rac are required for the establishment of cadherindependent cell-cell contacts. J Cell Biol 1997;137:1421-1431.
69. Braga VM, Betson M, Li X, et al. Activation of the small GTPase Rac is sufficient to disrupt cadherin-dependent cell-cell adhesion in normal human keratinocytes. Mol Biol Cell 2000;11:3703-3721.
70. Fukata M, Nakagawa M, Itoh N, et al. Involvement of IQGAP1, an effector of Rac1 and Cdc42 GTPases, in cell-cell dissociation during cell scattering. Mol Cell Biol 2001;21:2165-2183.
71. Sugimoto N, Imoto I, Fukuda Y, et al. IQGAP1, a negative regulator of cell-cell adhesion, is upregulated by gene amplification at 15q26 in gastric cancer cell lines HSC39 and 40A. J Hum Genet 2001;46:21-25.
72. Nabeshima K, Shimao Y, Inoue T, et al. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. Cancer Lett 2002;176:101-109.
73. Yonemasu H, Takashima M, Nishiyama KI, et al. Phenotypical characteristics of undifferentiated carcinoma of the pancreas: a comparison with pancreatic ductal adenocarcinoma and relevance of E-cadherin, alpha catenin and beta catenin expression. Oncol Rep 2001;8:745-752.
74. Noren NK, Niessen CM, Gumbiner BM, et al. Cadherin engagement regulates Rho family GTPases. J Biol Chem 2001;276:33,305-33,308.
75. Qiao Q, Ramadani M, Gansauge S, et al. Reduced membranous and ectopic cytoplasmic expression of betacatenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer. Int J Cancer 2001;95:194-197.
76. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2:91-100.
77. Kleer CG, van Golen KL, Zhang Y, et al. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 2002;160:579-584.
78. Kaneko K, Satoh K, Masamune A, et al. Expression of ROCK-1 in Human Pancreatic Cancer: Its Down-Regulation by Morpholino Oligo Antisense Can Reduce the Migration of Pancreatic Cancer Cells In Vitro. Pancreas 2002;24:251-257.
79. Akisawa N, Nishimori I, Iwamura T, et al. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 1999;258:395-400.
80. Matsui T, Maeda M, Doi Y, et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998;140:647-657.